Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Other Complications”

539 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 539 results

Early research (Phase 1)Study completedNCT00499135
What this trial is testing

Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors

Who this might be right for
Adult Solid NeoplasmClear Cell Renal Cell CarcinomaRecurrent Renal Cell Carcinoma+2 more
National Cancer Institute (NCI) 25
Not applicableLooking for participantsNCT03906435
What this trial is testing

Preventing Vulnerable Child Syndrome in the NICU With Cognitive Behavioral Therapy (PreVNT Trial)

Who this might be right for
Premature InfantMental Health Issue (E.G., Depression, Psychosis, Personality Disorder, Substance Abuse)Development, Child+1 more
University of Texas Southwestern Medical Center 100
Testing effectiveness (Phase 2)Looking for participantsNCT07024784
What this trial is testing

Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies

Who this might be right for
Gynecologic CancersPlatinum-Sensitive Ovarian CancerFallopian Tube Cancer+1 more
AbbVie 377
Early research (Phase 1)Looking for participantsNCT04890613
What this trial is testing

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Who this might be right for
Advanced Solid Tumor
Senhwa Biosciences, Inc. 52
Not applicableUnknownNCT04314440
What this trial is testing

Cognitive Processing in Preterm Infants and NICU Music Therapy

Who this might be right for
Other Preterm Infants
Saskatchewan Health Authority - Regina Area 102
Large-scale testing (Phase 3)Ended earlyNCT00771316
What this trial is testing

Clinical Trial to Study the Safety and Effectiveness of MK0826 and Other Antibiotic Therapy in Patients With Complicated Urinary Tract Infection (0826-054)

Who this might be right for
Urinary Tract Infections
Merck Sharp & Dohme LLC 6
Testing effectiveness (Phase 2)Looking for participantsNCT06677190
What this trial is testing

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Who this might be right for
Ovarian CancerOvarian CarcinomaEndometrial Cancer+5 more
Dana-Farber Cancer Institute 32
Not applicableStudy completedNCT01493817
What this trial is testing

Biomarkers in Samples From Younger Patients With Wilms Tumor

Who this might be right for
Wilms Tumor and Other Childhood Kidney Tumors
Children's Oncology Group 30
Not applicableStudy completedNCT03862092
What this trial is testing

Frequency of Putative Enteric Zoster Diagnosed Using Saliva Samples in Patients With Abdominal Pain: a Prospective Study

Who this might be right for
Abdominal PainZoster With Other Complications
Asan Medical Center 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07811297
What this trial is testing

Catequentinib Hydrochloride (AL3818) in Endometrial, LGSOC, STS or GBM Cancers

Who this might be right for
Endometrial NeoplasmsOvarian NeoplasmsSoft Tissue Sarcoma (STS)+1 more
Advenchen Pharmaceuticals, LLC. 138
Testing effectiveness (Phase 2)Study completedNCT02725710
What this trial is testing

Gabapentin as an Adjunct to Perioperative Pain Management Regimens for Uterine Aspiration

Who this might be right for
Other AbortionSpontaneous Abortion
Duke University 96
Testing effectiveness (Phase 2)Study completedNCT00624910
What this trial is testing

Efficacy and Safety of a Collagen Bupivacaine Implant in Women Following Abdominal Hysterectomy

Who this might be right for
Postoperative Pain
Innocoll 54
Not applicableStudy completedNCT01348334
What this trial is testing

Synthetic Mesh Materials In Sling Surgery

Who this might be right for
Incontinence
Ataturk Training and Research Hospital 144
Testing effectiveness (Phase 2)Active Not RecruitingNCT06390995
What this trial is testing

TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors

Who this might be right for
Ovarian CancerSolid Tumors
Takeda 28
Large-scale testing (Phase 3)Study completedNCT01190267
What this trial is testing

Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)

Who this might be right for
Schizophrenia, ParanoidSchizophrenia, DisorganizedSchizophrenia, Undifferentiated
Organon and Co 204
Not applicableStudy completedNCT03907605
What this trial is testing

Anti-Mullerian Hormone (AMH) is a Marker for Ovarian Reserve. There Are Many Studies About AMH Changes in Ovarian Surgery, But Little is Known for Other Surgeries. We Seek to Investigate the Hormone Variations Before and After Uterine Artey Ligation for Postpartum Hemorrage (PPH)

Who this might be right for
Anti-Mullerian Hormone DeficiencyPost Partum Hemorrhage
Kanuni Sultan Suleyman Training and Research Hospital 88
Post-approval studies (Phase 4)Ended earlyNCT03276026
What this trial is testing

Compare Neostigmine vs Sugammadex in Length of PACU Stay in Patients Undergoing Sleeve Gastrectomy Surgery

Who this might be right for
Postoperative Nausea and VomitingRespiratory Conditions Due to Other External Agents
Virtua Health, Inc. 68
Not applicableStudy completedNCT00655447
What this trial is testing

Examining the Long-Term Risks of Oophorectomy

Who this might be right for
Coronary Heart DiseaseStrokeBreast Cancer+4 more
Parker, William H., M.D. 32,175
Early research (Phase 1)Ended earlyNCT04895748
What this trial is testing

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Looking for participantsNCT07636785
What this trial is testing

And 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

Who this might be right for
Hepatocellular Carcinoma (HCC)Metastatic Uveal MelanomaRenal Cell Carcinoma (RCC)+2 more
VM Discovery, Inc. 111
Next Page